Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Longenecker

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patientsG D MacLean, M A Reddish, B M Longenecker
Cellular Immunology|February 1, 1986
Murine T-cell clones specific for chicken erythrocyte alloantigensM A Giedlin, B M Longenecker, T R Mosmann
Immunogenetics|February 9, 2011
Histocompatibility typing by cellular radioimmunoassayB M Longenecker, B Singh, M Gallatin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blastsT F Zipf, G J Lauzon, B M Longenecker
Annals of the New York Academy of Sciences|August 12, 1993
Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvantB M Longenecker, M Reddish, R Koganty, et al.
Biochemical and Biophysical Research Communications|July 17, 2001
Association of MUC-1 and SPGL-1 with low-density microdomain in T-lymphocytes: a preliminary noteK Handa, F Jacobs, B M Longenecker, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasisB M Longenecker, M Reddish, R Koganty, et al.
Cancer Research|September 29, 1998
Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulationB Agrawal, M J Krantz, J Parker, et al.
International Immunology|January 14, 1999
Rapid induction of primary human CD4+ and CD8+ T cell responses against cancer-associated MUC1 peptide epitopesB Agrawal, M J Krantz, M A Reddish, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|February 1, 2003
Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigenJ Schuman, A P Campbell, R R Koganty, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patientsG D MacLean, M A Reddish, B M Longenecker
Cellular Immunology|February 1, 1986
Murine T-cell clones specific for chicken erythrocyte alloantigensM A Giedlin, B M Longenecker, T R Mosmann
Immunogenetics|February 9, 2011
Histocompatibility typing by cellular radioimmunoassayB M Longenecker, B Singh, M Gallatin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blastsT F Zipf, G J Lauzon, B M Longenecker
Annals of the New York Academy of Sciences|August 12, 1993
Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvantB M Longenecker, M Reddish, R Koganty, et al.
Biochemical and Biophysical Research Communications|July 17, 2001
Association of MUC-1 and SPGL-1 with low-density microdomain in T-lymphocytes: a preliminary noteK Handa, F Jacobs, B M Longenecker, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasisB M Longenecker, M Reddish, R Koganty, et al.
Cancer Research|September 29, 1998
Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulationB Agrawal, M J Krantz, J Parker, et al.
International Immunology|January 14, 1999
Rapid induction of primary human CD4+ and CD8+ T cell responses against cancer-associated MUC1 peptide epitopesB Agrawal, M J Krantz, M A Reddish, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|February 1, 2003
Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigenJ Schuman, A P Campbell, R R Koganty, et al.
Pageof 12